David McWilliams insider trades: Greenwich LifeSciences (GLSI) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where David reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 14, 2021 | GLSI | ↑ Buy | 200 | $27.56 | $6K | Direct | Dec 16, 2021 (2d) |
| Nov 20, 2020 | GLSI | ↑ Buy | 1,500 | $5.40 | $8K | Direct | Nov 24, 2020 (4d) |
| Sep 29, 2020 | GLSI | ↑ Buy | 2,608 | $5.75 | $15K | Direct | Sep 29, 2020 (0d) |
| Dec 14, 2005 | PFTR.OB | ↑ Buy | 2,000 | $0.63 | $1K | Direct | Dec 15, 2005 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other GLSI insiders
Open-market trades in the last 12 months
About David McWilliams's insider trades
David McWilliams is a director at Greenwich LifeSciences (GLSI). Since Dec 14, 2005, David has reported 4 open-market purchases worth $30K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (8 filings), other transactions (4 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every GLSI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.